XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS (Tables)
3 Months Ended
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF DEFERRED COMPENSATION ARRANGEMENT WITH INDIVIDUAL

On October 31, 2022, the Compensation Committee and the Board approved the following cash bonuses to the following executive officers, whereby the final cash bonus payout was determined based on a payout percentage of the executive’s previous target cash bonus for fiscal year 2022:

 

Name  Position  Target Cash Bonus   Payout Percentage   Cash Bonus Payout 
Ronald F. Dutt  Chief Executive Officer  $137,500    40%  $55,055.00 
Charles Scheiwe  Chief Financial Officer  $71,820    40%  $28,756.73 
SCHEDULE OF DEFERRED COMPENSATION ARRANGEMENT WITH INDIVIDUAL, SHARE BASED COMPENSATION

The following executive officers of the Company were granted Options under the 2021 Plan in such number and vesting schedule set forth as follows:

 

Name  Position  Options*  Vesting Schedule
Ronald F. Dutt  Chief Executive Officer  80,175  Four (4) equal annual installments commencing one year after the Grant Date
Charles Scheiwe  Chief Financial Officer  41,878  Four (4) equal annual installments commencing one year after the Grant Date

 

* Subject to $100,000 ISO limitation under the 2021 Plan

2023 Bonus Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF DEFERRED COMPENSATION ARRANGEMENT WITH INDIVIDUAL

The Compensation Committee approved the target cash bonuses under the 2023 Bonus based on the base salary for fiscal year 2023 for the following executive officers:

 

Name  Position  Base Salary   Bonus Percentage of Base Salary   Total Target Payout   Maximum Payout(1) 
Ronald F. Dutt  Chief Executive Officer  $300,000(2)   75%  $225,000   $270,000 
Charles Scheiwe  Chief Financial Officer  $205,200    35%  $71,820   $86,184 

 

(1) Subject to a bonus cap for achieving above set revenue target and a payout cap for achieving 10% positive Adjusted EBITDA.

 

(2) To be effective during the second fiscal quarter of 2023.